KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Receivables (2016 - 2025)

Historic Receivables for Neogenomics (NEO) over the last 16 years, with Q3 2025 value amounting to $155.3 million.

  • Neogenomics' Receivables rose 255.43% to $155.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.3 million, marking a year-over-year increase of 255.43%. This contributed to the annual value of $150.6 million for FY2024, which is 1476.11% up from last year.
  • Latest data reveals that Neogenomics reported Receivables of $155.3 million as of Q3 2025, which was up 255.43% from $153.1 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Receivables registered a high of $155.3 million during Q3 2025, and its lowest value of $105.3 million during Q1 2021.
  • Its 5-year average for Receivables is $129.3 million, with a median of $126.2 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Neogenomics' Receivables was 2152.46% (2021), while the steepest drop was 152.98% (2021).
  • Over the past 5 years, Neogenomics' Receivables (Quarter) stood at $114.1 million in 2021, then rose by 6.6% to $121.6 million in 2022, then increased by 7.91% to $131.3 million in 2023, then rose by 14.76% to $150.6 million in 2024, then grew by 3.09% to $155.3 million in 2025.
  • Its Receivables stands at $155.3 million for Q3 2025, versus $153.1 million for Q2 2025 and $151.2 million for Q1 2025.